Quickstart Highlights

Cagrilintide is a long‑acting acylated analogue of the pancreatic hormone amylin, designed for once‑weekly subcutaneous administration^[1]. It activates central amylin receptors to promote satiety, slow gastric emptying, and reduce food intake^[2][3]. In phase 2 and phase 3 trials, cagrilintide produced dose‑dependent weight loss with a predominantly gastrointestinal side‑effect profile^[4][5].

• Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.
• Typical weekly range: 0.6–4.5 mg once weekly (gradual titration over 4–6 weeks).
• Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 0.0167 mg (16.7 mcg) on a U‑100 insulin syringe.
• Storage: Lyophilized: store frozen at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days.

Protocol Overview

Concise summary of the once‑weekly regimen.

• Goal: Support satiety, reduce food intake, and promote weight management over time^[2][4].
• Schedule: Weekly subcutaneous injections for 12–16 weeks (or longer as appropriate).
• Dose Range: 0.6–4.5 mg weekly with gradual titration every 2 weeks.
• Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for practical volume measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw cycles.

Dosing Protocol

Suggested weekly titration approach based on clinical trial designs^[1][6].

• Start: 0.6 mg weekly for the first 2 weeks to assess tolerability.
• Escalate: Double the dose every 2 weeks (0.6 → 1.2 → 2.4 → 4.5 mg) as tolerated.
• Target: 4.5 mg weekly by Weeks 7–8; maintain at this dose.
• Frequency: Once per week (subcutaneous) on the same day each week.
• Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide integrity and potency.

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 30 days and avoid freeze–thaw cycles.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and tolerability.

• Use new sterile syringes for each injection; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) weekly to reduce local irritation.
• Gradual dose escalation minimizes gastrointestinal side effects such as nausea^[4][6].
• Document weekly dose, injection site, and any adverse effects to maintain consistency.
• For maintenance doses requiring >1.0 mL, ensure you have appropriately sized syringes (3 mL).

How This Works

Cagrilintide is an acylated, long‑acting analogue of amylin—a hormone co‑secreted with insulin from pancreatic beta cells^[2][7]. Native amylin promotes satiation, slows gastric emptying, and inhibits postprandial glucagon secretion^[8][9]. By acting on central amylin receptors (particularly in the area postrema and hindbrain), cagrilintide reduces appetite and energy intake^[3][10]. Lipid modifications extend its half‑life to approximately 160–195 hours, enabling once‑weekly dosing^[6][11].

Potential Benefits & Side Effects

Observations from phase 2 and phase 3 clinical trials.

• Weight reduction: In the phase 2 trial, cagrilintide 4.5 mg weekly produced approximately 10.8% body weight loss over 26 weeks versus 3.0% with placebo^[4].
• Combination therapy: When combined with semaglutide 2.4 mg (CagriSema), phase 3 REDEFINE trials showed approximately 20% weight loss at 68 weeks, exceeding results with either agent alone^[5][12].
• Dose‑dependent efficacy: Higher doses (2.4–4.5 mg) demonstrate greater weight loss than lower doses (0.3–1.2 mg)^[4].
• Side effects: Primarily gastrointestinal—nausea, vomiting, diarrhea, and constipation—which are generally mild‑to‑moderate and transient^[4][5]. Gradual titration helps minimize these effects.
• Injection‑site reactions: Occasional mild redness or irritation at subcutaneous injection sites.

Lifestyle Factors

Complementary strategies for optimal outcomes.

• Pair with a balanced, protein‑forward diet tailored to individual energy needs.
• Combine resistance training and aerobic activity to support metabolic health and preserve lean mass.
• Prioritize adequate sleep (7–9 hours) and stress management for adherence and recovery.
• Monitor hydration and electrolytes, especially if experiencing gastrointestinal side effects.

Injection Technique

General subcutaneous guidance from clinical best‑practice resources^[13][14].

• Clean the vial stopper and skin with alcohol; allow to air dry completely.
• Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue^[13].
• Do not aspirate for subcutaneous injections; inject slowly and steadily.
• Hold for 5–10 seconds before withdrawing the needle to ensure complete delivery.
• Rotate sites systematically (abdomen, thighs, upper arms) each week to avoid lipohypertrophy^[14].

Recommended Source

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

Shop at Amino Labs

References